UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

1243P Pathologic response as early endpoint for survival following neoadjuvant therapy (NEO-AT) in resectable non-small cell lung cancer (rNSCLC): Systematic literature review and meta-analysis

Annals of oncology, 2020-09, Vol.31, p.S806-S806

2020

Volltextzugriff (PDF)

Long-term survivorship for patients with non-small cell lung cancer (NSCLC) treated with nivolumab (nivo): a response-based modeling approach

European journal of cancer (1990), 2017-02, Vol.72, p.S135-S136

2017

Volltextzugriff (PDF)

3095 Subsequent line of therapy in metastatic NSCLC (mNSCLC): An indicator of success or failure?

European journal of cancer (1990), 2015-09, Vol.51, p.S631-S632

2015

Volltextzugriff (PDF)

Comparative efficacy and safety of nivolumab (nivo) vs relevant treatments (txs) in pretreated squamous (SQ) advanced non-small cell lung cancer (aNSCLC): Results from a systematic literature review (SLR) and indirect treatment comparisons (ITCs) of randomized controlled trials (RCTs)

European journal of cancer (1990), 2017-02, Vol.72, p.S136-S136

2017

Volltextzugriff (PDF)

Comparative efficacy and safety of nivolumab (nivo) vs relevant treatments (txs) in pretreated non-squamous (NSQ) advanced non-small cell lung cancer (aNSCLC): Results from a systematic literature review (SLR) and indirect treatment comparisons (ITCs) of randomized controlled trials (RCTs)

European journal of cancer (1990), 2017-02, Vol.72, p.S136-S136

2017

Volltextzugriff (PDF)

Cost-effectiveness of Mandibular Two-implant Overdentures and Conventional Dentures in the Edentulous Elderly

Journal of dental research, 2005-09, Vol.84 (9), p.794-799

2005

Volltextzugriff (PDF)

3011 Evaluation of overall health status in patients with advanced squamous non-small cell lung cancer treated with nivolumab or docetaxel in CheckMate 017

European journal of cancer (1990), 2015-09, Vol.51, p.S599-S600

2015

Volltextzugriff (PDF)

Assessing the Burden of Caregiving for Patients with Lung Cancer in Europe

Value in health, 2013-11, Vol.16 (7), p.A403-A403

2013

Volltextzugriff (PDF)

Real-World Use of Systemic Anticancer Treatment by Histology and Line of Therapy in U.S. Medicare Patients With Advanced Non-Small Cell Lung Cancer

International journal of radiation oncology, biology, physics, 2014-11, Vol.90 (5), p.S58-S59

2014

Volltextzugriff (PDF)

CO27 Survival and Cost of Care By Type of First-Line Therapy in Metastatic Non-Small Lung Cancer Using SEER-Medicare Data

Value in health, 2024-06, Vol.27 (6), p.S21-S21

2024

Volltextzugriff (PDF)

P2.30-02 Assessing the Impact of Using Disease-Specific Novel Value Elements on Cost-Effectiveness Results in Lung Cancer

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S406

2023

Volltextzugriff (PDF)

The Direct Health Care Cost Of Prostate Cancer: Evidence From Us National Survey Data

Value in health, 2013-05, Vol.16 (3), p.A135-A135

2013

Volltextzugriff (PDF)

Cost Of Lost Productivity Due To Prostate Cancer: Evidence From Us National Survey Data

Value in health, 2013-05, Vol.16 (3), p.A135-A135

2013

Volltextzugriff (PDF)

Determinants Of Initial Treatment For Advanced Melanoma

Value in health, 2013-05, Vol.16 (3), p.A154-A154

2013

Volltextzugriff (PDF)

The Labor Productivity Effects Of Prostate Cancer Patients On Spouses And Other Family Members: Evidence From Us National Survey Data

Value in health, 2013-05, Vol.16 (3), p.A135-A136

2013

Volltextzugriff (PDF)

Survival Of Patients With Advanced Melanoma In A Real World Setting

Value in health, 2013-05, Vol.16 (3), p.A129-A129

2013

Volltextzugriff (PDF)

The Impact Of Prostate Cancer On Quality Of Life

Value in health, 2013-05, Vol.16 (3), p.A136-A136

2013

Volltextzugriff (PDF)

HTA14 Expanding the HTA Cost-Effectiveness Analyses for CheckMate 9LA: Nivolumab Plus Ipilimumab Plus Chemotherapy As First-Line Strategy for Non-Small Cell Lung Cancer

Value in health, 2023-12, Vol.26 (12), p.S322

2023

Volltextzugriff (PDF)

EE40 Identifying and Quantifying Elements of Value for Nivolumab and Ipilimumab in First-Line Non-Small Cell Lung Cancer

Value in health, 2023-06, Vol.26 (6), p.S66-S66

2023

Volltextzugriff (PDF)

9113 POSTER Total Direct and Segmented Medical Cost-of-Care for Stage IV (Adv) Non-Small Cell Lung Cancer (NSCLC) in a Private Insurance Population

European journal of cancer (1990), 2011, Vol.47, p.S626-S626

2011

Volltextzugriff (PDF)

9114 POSTER Patient Characteristics in a Cohort of Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Treated in the Community Setting

European journal of cancer (1990), 2011, Vol.47, p.S627-S627

2011

Volltextzugriff (PDF)

PSS28 Economic Burden of Advanced Melanoma: Findings From A Large US Health Insurance Database

Value in health, 2011, Vol.14 (7), p.A507-A507

2011

Volltextzugriff (PDF)

1455P Nivolumab (nivo) resumption in patients with advanced or metastatic non-small cell lung cancer (aNSCLC): Survival outcomes based on France and Germany real-world data (RWD)

Annals of oncology, 2023-10, Vol.34, p.S827-S827

2023

Volltextzugriff (PDF)

PCN91 Estimating EQ-5D Utilities for Cost-Effectiveness Models Involving Immuno-Oncology Treatments

Value in health, 2020-12, Vol.23, p.S438-S438

2020

Volltextzugriff (PDF)

EP11.03-23 Efficacy of Nivolumab + Ipilimumab Vs other First-line Treatments for Metastatic NSCLC with PD-L1 <1%: a Network Meta-analysis

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S629-S630

2023

Volltextzugriff (PDF)

1 – 25 von 82

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(82)
Mit Volltextzugriff
(82)

Publikationsform

Artikel
(82)

Sprache

Englisch
(82)

Erscheinungsjahr

n.n

Zeitschrift / Serie

Value In Health
(40)
Annals Of Oncology
(20)
European Journal Of Cancer
(10)
Journal Of Thoracic Oncology
(6)
International Journal Of Radiation Oncology, Biology, Physics
(2)
Lung Cancer
(2)
Journal Of Dental Research
(1)
The Journal Of Prosthetic Dentistry
(1)

3 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

1243P Pathologic response as early endpoint for survival following neoadjuvant therapy (NEO-AT) in resectable non-small cell lung cancer (rNSCLC): Systematic literature review and meta-analysis

Long-term survivorship for patients with non-small cell lung cancer (NSCLC) treated with nivolumab (nivo): a response-based modeling approach

3095 Subsequent line of therapy in metastatic NSCLC (mNSCLC): An indicator of success or failure?

Comparative efficacy and safety of nivolumab (nivo) vs relevant treatments (txs) in pretreated squamous (SQ) advanced non-small cell lung cancer (aNSCLC): Results from a systematic literature review (SLR) and indirect treatment comparisons (ITCs) of randomized controlled trials (RCTs)

Comparative efficacy and safety of nivolumab (nivo) vs relevant treatments (txs) in pretreated non-squamous (NSQ) advanced non-small cell lung cancer (aNSCLC): Results from a systematic literature review (SLR) and indirect treatment comparisons (ITCs) of randomized controlled trials (RCTs)

Cost-effectiveness of Mandibular Two-implant Overdentures and Conventional Dentures in the Edentulous Elderly

3011 Evaluation of overall health status in patients with advanced squamous non-small cell lung cancer treated with nivolumab or docetaxel in CheckMate 017

Assessing the Burden of Caregiving for Patients with Lung Cancer in Europe

Real-World Use of Systemic Anticancer Treatment by Histology and Line of Therapy in U.S. Medicare Patients With Advanced Non-Small Cell Lung Cancer

CO27 Survival and Cost of Care By Type of First-Line Therapy in Metastatic Non-Small Lung Cancer Using SEER-Medicare Data

P2.30-02 Assessing the Impact of Using Disease-Specific Novel Value Elements on Cost-Effectiveness Results in Lung Cancer

The Direct Health Care Cost Of Prostate Cancer: Evidence From Us National Survey Data

Cost Of Lost Productivity Due To Prostate Cancer: Evidence From Us National Survey Data

Determinants Of Initial Treatment For Advanced Melanoma

The Labor Productivity Effects Of Prostate Cancer Patients On Spouses And Other Family Members: Evidence From Us National Survey Data

Survival Of Patients With Advanced Melanoma In A Real World Setting

The Impact Of Prostate Cancer On Quality Of Life

HTA14 Expanding the HTA Cost-Effectiveness Analyses for CheckMate 9LA: Nivolumab Plus Ipilimumab Plus Chemotherapy As First-Line Strategy for Non-Small Cell Lung Cancer

EE40 Identifying and Quantifying Elements of Value for Nivolumab and Ipilimumab in First-Line Non-Small Cell Lung Cancer

9113 POSTER Total Direct and Segmented Medical Cost-of-Care for Stage IV (Adv) Non-Small Cell Lung Cancer (NSCLC) in a Private Insurance Population

9114 POSTER Patient Characteristics in a Cohort of Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Treated in the Community Setting

PSS28 Economic Burden of Advanced Melanoma: Findings From A Large US Health Insurance Database

1455P Nivolumab (nivo) resumption in patients with advanced or metastatic non-small cell lung cancer (aNSCLC): Survival outcomes based on France and Germany real-world data (RWD)

PCN91 Estimating EQ-5D Utilities for Cost-Effectiveness Models Involving Immuno-Oncology Treatments

EP11.03-23 Efficacy of Nivolumab + Ipilimumab Vs other First-line Treatments for Metastatic NSCLC with PD-L1 <1%: a Network Meta-analysis

Suchergebnisse filtern